Currently patients with glioblastoma have a median survival of approximately 14.6 months and 5-year survival rates below 5%.

Kazia Therapeutics Limited , an oncology-focused drug development company, today announced that a patient with stage IV triple-negative breast cancer (TNBC) treated under an FDA-authorized ...

Infectious meningoencephalitis, characterized by inflammation of both the brain and adjacent meninges, is caused by a variety ...

Magnetic resonance imaging (MRI) is a non-invasive biomedical imaging technique that uses a strong oscillating magnetic field to induce endogenous atoms such as hydrogen, or exogenously added contrast ...